Latest Breaking News On - Rectal cancer center - Page 1 : vimarsana.com

Obesity and Cancer: Untangling a Complex Web

Although more than 40% of cancers are considered obesity-related, excess weight is often just a contributing risk factor, leaving uncertainty about the role weight plays in cancer risk.

University of arizonaUnited statesNew havenDana farber cancer instituteJenniferw beaKarenm basen engquistJeffreya meyerhardtLeah ferrucciInternational agency for research on cancerPopulation servicesDivision of cancer preventionCenters for diseaseAmerican cancer societyUniversity of texas md anderson cancer centerNurse health studyYale school of public health

Dual-Action Drug Produces Positive Results in Patients With Advanced Neuroendocrine Tumors, Trial Finds

A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.

United statesJennifer chanJeffrey meyerhardtNational institutes of healthAlliance for clinical trials in oncologyNational cancer instituteEuropean society for medical oncologyCancer therapy evaluation programProgram in carcinoidDana farber cancer instituteNational clinical trials networkRectal cancer center at dana farberDrug administrationCongress onNeuroendocrine tumorsEuropean society

Dual-action drug produces shows promising results in neuroendocrine tumor trial

A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.

United statesJennifer chanJeffrey meyerhardtLily ramseyRectal cancer center at dana farberDana farber cancer instituteCancer therapy evaluation programCongress onNational clinical trials networkAlliance for clinical trials in oncologyEuropean society for medical oncologyNational cancer instituteNational institutes of healthDrug administrationProgram in carcinoidNeuroendocrine tumors

Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds

Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesJennifer chanJeffrey meyerhardtNational clinical trials networkDrug administrationDana farber cancer instituteCongress onProgram in carcinoidNational cancer instituteRectal cancer center at dana farberEuropean society for medical oncologyNeuroendocrine tumorsEuropean societyMedical oncologyRectal cancer centerDouble blinded study

Dual-Action Drug Shows Promise in Neuroendocrine Tumor Trial

Dual-Action Drug Shows Promise in Neuroendocrine Tumor Trial
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesJennifer chanJeffrey meyerhardtNational clinical trials networkNational institutes of healthAlliance for clinical trials in oncologyNational cancer instituteEuropean society for medical oncologyDrug administrationProgram in carcinoidCongress onDana farber cancer instituteRectal cancer center at dana farberCancer therapy evaluation programNeuroendocrine tumorsEuropean society